{"gene":"FGF4","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1987,"finding":"The hst (FGF4) gene encodes a 206 amino acid open reading frame that is sufficient for transforming activity when expressed in NIH3T3 cells via an SV40 promoter-containing vector.","method":"cDNA cloning, expression vector transfection, NIH3T3 transformation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro transformation assay with defined coding sequence, foundational paper","pmids":["2953031"],"is_preprint":false},{"year":1991,"finding":"FGF4 (K-fgf/hst) transforms cells through an autocrine mechanism that requires secretion and extracellular receptor activation at the cell surface; deletion of the signal peptide or retention of the protein in the ER (KDEL motif) abolishes transforming activity, and anti-FGF4 neutralizing antibodies reverse the transformed phenotype.","method":"Signal peptide deletion mutants, KDEL retention mutants, NIH3T3 focus formation assay, neutralizing antibody treatment, soft-agar and serum-free growth assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis of signal peptide + KDEL retention + antibody reversal, multiple orthogonal methods in one study","pmids":["1990270"],"is_preprint":false},{"year":1991,"finding":"Cell transformation by kFGF requires secretion but not glycosylation; cytoplasmic or ER-retained kFGF mutants fail to transform NIH3T3 cells, and suramin reverses transformation by both glycosylated and unglycosylated secreted forms.","method":"Glycosylation site mutagenesis, KDEL retention mutant, NIH3T3 transformation assay, suramin inhibition","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis plus pharmacological inhibition, replicated conclusion from independent lab","pmids":["1655808"],"is_preprint":false},{"year":1991,"finding":"The kFGF/FGF4 gene enhancer contains an octamer-binding sequence that binds Oct1 and Oct4 (but not Oct1 alone after differentiation), indicating that Oct4 positively regulates FGF4 transcription in undifferentiated embryonal carcinoma and embryonic stem cells.","method":"CAT reporter assays, electrophoretic mobility shift assay (EMSA), transfection into EC/ES cells","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assay + EMSA, single lab","pmids":["1723621"],"is_preprint":false},{"year":1992,"finding":"FGF4 signaling for myoblast repression requires heparan sulfate proteoglycans (HSPG); chlorate-mediated inhibition of glycosaminoglycan sulfation abrogates FGF4 biological activity, which is restored by heparin or sodium sulfate co-addition.","method":"Chlorate treatment of MM14 myoblasts, heparitinase treatment, FGF binding assay, differentiation assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — biochemical inhibition plus rescue with heparin, multiple orthogonal methods","pmids":["1379245"],"is_preprint":false},{"year":1994,"finding":"FGF4 protein expressed in the enamel knot stimulates proliferation of both dental epithelial and mesenchymal cells in vitro, while the enamel knot cells themselves do not divide, supporting a paracrine growth-stimulating role during tooth cusp morphogenesis.","method":"In situ hybridization, in vitro FGF4 protein addition to isolated dental tissues, cell proliferation assessment","journal":"The International journal of developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro FGF4 protein addition with proliferation readout, single lab","pmids":["7848830"],"is_preprint":false},{"year":1994,"finding":"FGF4 promotes differentiation of parietal endoderm from isolated inner cell mass (ICM) cells and increases secretion of 92 kDa gelatinase and tissue plasminogen activator; FGFR-3 and FGFR-4 receptors are expressed on all blastocyst cells.","method":"Immunosurgery ICM isolation, recombinant FGF4 culture, morphological analysis, zymography, receptor expression by Northern blot","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 — direct protein addition to isolated ICM with defined cellular readouts, single lab","pmids":["7925026"],"is_preprint":false},{"year":1994,"finding":"FGF4 angiogenic activity is demonstrated in vivo by chick chorioallantoic membrane assay and rat cornea assay using recombinant hst-1 protein produced in E. coli.","method":"Recombinant protein production in E. coli, CAM assay, rat cornea assay, nude mouse tumor vascularization","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 — two in vivo angiogenesis assays with recombinant protein, single lab","pmids":["7520355"],"is_preprint":false},{"year":1994,"finding":"The FGF4 gene is positively regulated by an upstream NF-Y binding site (sequence CTGATTGGCA) in its promoter that cooperates with the downstream octamer enhancer in F9 embryonal carcinoma cells.","method":"CAT reporter assays, deletion/mutation analysis, EMSA, methylation interference, anti-NF-Y antibody supershift","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assay with mutagenesis + EMSA + antibody validation, single lab","pmids":["7929190"],"is_preprint":false},{"year":1994,"finding":"Adenovirus-mediated HST-1/FGF4 gene transfer in vivo causes a twofold increase in peripheral platelet count and increased megakaryocyte numbers in bone marrow and spleen, demonstrating an in vivo thrombopoietic role.","method":"Adenovirus-mediated gene transfer in nude mice, platelet counting, histology of bone marrow and spleen, recombinant protein injection","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — adenoviral gene delivery in vivo with defined hematological phenotype, single lab","pmids":["7809043"],"is_preprint":false},{"year":1995,"finding":"FGF-4 gene expression requires synergistic action of Sox2 and Oct-3 on adjacent binding sites in the downstream enhancer; Sox2 forms a ternary complex with Oct-3 (but not Oct-1) on FGF-4 enhancer DNA, and only the Sox2/Oct-3 complex drives transcriptional activation.","method":"cDNA cloning of Sox2 from F9 cells, CAT reporter assays, EMSA, ternary complex formation experiments","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — ternary complex reconstitution on defined DNA element + reporter assays with multiple factor combinations, strong mechanistic evidence","pmids":["7590241"],"is_preprint":false},{"year":1995,"finding":"Homozygous disruption of Fgf4 by gene targeting causes early postimplantation lethality with severely impaired inner cell mass proliferation; this ICM proliferation defect is rescued by exogenous FGF4 protein in vitro, demonstrating an essential mitogenic role for FGF4 in early embryogenesis.","method":"Gene targeting (knockout), embryo culture, exogenous FGF4 protein rescue experiment","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — loss-of-function genetic model + protein rescue, foundational paper","pmids":["7809630"],"is_preprint":false},{"year":1995,"finding":"HST-1/FGF4 antisense oligodeoxynucleotides block mouse limb bud outgrowth in an organ culture system, while sense and scrambled ODNs have no effect, establishing a required role for FGF4 in limb development.","method":"Antisense oligodeoxynucleotide treatment, limb bud organ culture, morphological assessment","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — antisense knockdown with defined limb phenotype and controls, single lab","pmids":["7642715"],"is_preprint":false},{"year":1995,"finding":"Adenovirus-mediated FGF4 gene transfer effectively prevents chemotherapy- and irradiation-induced thrombocytopenia in mice by stimulating megakaryocyte production, with sustained serum FGF4 elevation for ≥30 days.","method":"Adenoviral gene transfer, thrombocytopenic mouse model (chemotherapy/irradiation), platelet counting, bone marrow histology","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo gene delivery with defined hematological rescue phenotype, single lab","pmids":["7635948"],"is_preprint":false},{"year":1998,"finding":"FGF4 produced by the AER promotes trophoblast stem cell proliferation; culture of mouse blastocysts or early postimplantation trophoblasts with FGF4 allows isolation of permanent trophoblast stem cell lines that differentiate in vitro upon FGF4 withdrawal.","method":"Blastocyst culture with recombinant FGF4, trophoblast stem cell line derivation, in vitro differentiation, in vivo chimera analysis","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1–2 — FGF4 addition/withdrawal experiments with defined stem cell and differentiation readouts, replicated across multiple cell lines and in vivo chimeras, highly cited foundational paper","pmids":["9851926"],"is_preprint":false},{"year":1998,"finding":"FGF4 antagonizes BMP-induced apoptosis and BMP-induced chondrogenesis in chick limb buds; FGF4 prevents BMP-mediated mesenchyme apoptosis and nullifies BMP4-induced ectopic chondrogenesis when co-applied.","method":"Bead implantation into chick limb buds, apoptosis assessment, chondrocyte condensation analysis","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo bead implantation with defined cellular readouts, single lab","pmids":["9507096"],"is_preprint":false},{"year":1999,"finding":"FGF4 in the AER is maintained by a SHH/FGF4 feedback loop: SHH signaling in the posterior mesenchyme induces Gremlin (a BMP antagonist) which relays the signal to induce Fgf4 expression in the AER; grafting Gremlin-expressing cells into limb deformity mutant limb buds rescues Fgf4 expression.","method":"Mouse mutant analysis (Shh-null, limb deformity mutants), Gremlin cell grafting rescue experiment, in situ hybridization","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in multiple mutants + cell graft rescue, replicated across multiple mutant lines","pmids":["10524628"],"is_preprint":false},{"year":1999,"finding":"FGF4 provides a vertical signal (from notochord) that induces En1 expression in the midbrain neural plate; exogenous FGF4 mimics the notochord requirement for En1 induction in neural plate explants in vitro.","method":"Avian embryo tissue recombination, notochord ablation, FGF4 protein addition to neural plate explants in vitro","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 — tissue recombination + protein addition with defined molecular readout, single lab","pmids":["9927596"],"is_preprint":false},{"year":2000,"finding":"Conditional inactivation of Fgf4 in the mouse AER using Cre/loxP results in normal limb development with normal Shh, Bmp2, Fgf8, and Fgf10 expression, demonstrating that FGF4 alone is not essential for AER-mediated limb patterning and that the FGF4-SHH feedback loop is not required.","method":"Conditional knockout (Cre/loxP), limb morphology analysis, in situ hybridization for target genes","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1 — conditional genetic loss-of-function with reporter and molecular readouts, well-controlled study","pmids":["10662638"],"is_preprint":false},{"year":2000,"finding":"Conditional inactivation of Fgf4 in the mouse AER does not impair Shh expression or limb formation, but Shh is required for maintenance of Fgf9 and Fgf17 (but not Fgf8) in the AER; combined activities of multiple AER-FGFs function in the positive feedback loop with Shh.","method":"Conditional knockout (Cre/loxP), double mutant analysis, in situ hybridization","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 — conditional KO with epistasis analysis across multiple FGF genes, replicated the Moon 2000 result independently","pmids":["10802662"],"is_preprint":false},{"year":2001,"finding":"Misexpression of Fgf-4 in the chick limb inhibits myogenesis by downregulating the FGF receptor Frek in muscle progenitors, leading to decreased myoblast proliferation and inhibition of terminal differentiation.","method":"Replication-competent retrovirus (RCAS) overexpression in chick limb, quail-chick transplantation cell tracking, in situ hybridization for muscle markers","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — retroviral overexpression with cell tracking and molecular readout, single lab","pmids":["11319857"],"is_preprint":false},{"year":2002,"finding":"FGF4 is a direct transcriptional target of LEF1/Wnt signaling; LEF1 binds the Fgf4 promoter, Fgf4 is absent in Lef1-null tooth rudiments, and FGF4-soaked beads fully rescue the developmental arrest of Lef1-/- tooth germs. FGF4 then induces Fgf3 in dental mesenchyme and both epithelial and mesenchymal FGFs induce Shh.","method":"Lef1 knockout analysis, chromatin immunoprecipitation/reporter assay for LEF1 binding to Fgf4, bead rescue experiment in Lef1-/- tooth organ culture","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 — direct transcriptional target identification + genetic rescue by protein application, multiple orthogonal methods","pmids":["12502739"],"is_preprint":false},{"year":2002,"finding":"Fgf4 expressed in limb muscle is required for maintenance of tendon markers scleraxis and tenascin; exogenous FGF4 restores scleraxis and tenascin expression in muscleless and aneural limbs, but does not restore Fgf8 expression in tendons.","method":"Muscleless and aneural chick limb models, FGF4 bead implantation, in situ hybridization for tendon markers","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-FGF4-source model with bead rescue and molecular readouts, single lab","pmids":["12086472"],"is_preprint":false},{"year":2003,"finding":"FGF4 acts paraculturally to maintain trophectoderm and primitive endoderm identity at E4.5; loss of zygotic FGF4 leads to failure of differentiation and function of extraembryonic cell types rather than a strictly mitogenic defect.","method":"Fgf4 null embryo analysis, in vitro culture experiments with FGF4 protein","journal":"Genesis (New York, N.Y. : 2000)","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function with defined lineage phenotype, single lab","pmids":["12748966"],"is_preprint":false},{"year":2003,"finding":"FGF-4 induces proliferation of cardiac cushion mesenchymal cells; FGF-4 protein localizes in cushion mesenchyme and activates FGFR2, and retroviral overexpression of FGF-4 in vivo expands cushion mesenchyme toward the lumen, promoting early valve leaflet formation.","method":"Immunolocalization, in situ hybridization for FGFRs, BrdU incorporation assay, retroviral FGF-4 overexpression in chick embryo, FGF-4 microinjection with BrdU","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo proliferation assays with retroviral overexpression and protein injection, single lab","pmids":["12798286"],"is_preprint":false},{"year":2004,"finding":"Combined loss of Fgf4 and Fgf8 in the forelimb AER causes failure of limb bud mesenchyme survival and loss of Shh and Fgf10 expression, demonstrating that FGF4 functionally compensates for FGF8 in supporting limb mesenchyme viability.","method":"Double conditional knockout (Cre/loxP for Fgf4 and Fgf8), apoptosis analysis, in situ hybridization for Shh and Fgf10","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1 — double conditional KO with defined apoptotic phenotype and molecular marker analysis","pmids":["15328019"],"is_preprint":false},{"year":2004,"finding":"HST-1/FGF-4 protects male germ cells from heat-stress-induced apoptosis by activating the MAPK survival cascade in germ cells and by stimulating lactate production from Sertoli cells, which is an indispensable nutrient for germ cell survival.","method":"Adenoviral FGF4 gene delivery to mouse testes, hyperthermia model, TUNEL apoptosis assay, MAPK activation by western blot, lactate production measurement","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 — adenoviral gain-of-function with TUNEL, signaling, and metabolic readouts, single lab","pmids":["14980503"],"is_preprint":false},{"year":2005,"finding":"FGF4 can functionally replace FGF8 in limb skeletal development: when Fgf4 is expressed in place of Fgf8 via conditional allele switching, all Fgf8 inactivation-induced skeletal defects are rescued; excess FGF4 signaling causes polydactyly and syndactyly.","method":"Conditional Fgf4 gain-of-function allele activation simultaneous with Fgf8 inactivation via Cre recombinase, skeletal preparation analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1 — conditional allele-swap genetic rescue with defined skeletal phenotype, elegant single-experiment proof of functional equivalence","pmids":["16308330"],"is_preprint":false},{"year":2010,"finding":"The histone demethylase KDM7A (KIAA1718) directly activates FGF4 transcription by removing repressive H3K9me2 and H3K27me2 marks at the FGF4 locus; knockdown of KDM7A blocks neural differentiation and this is rescued by wild-type but not catalytically inactive KDM7A; this pro-neural effect is mediated through FGF4.","method":"KDM7A knockdown in mouse ESCs, rescue with wild-type vs. catalytic mutant KDM7A, ChIP for histone marks at Fgf4 locus, neural differentiation assays","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP for direct histone mark changes at Fgf4 locus + catalytic mutant rescue, multiple orthogonal methods","pmids":["20084082"],"is_preprint":false},{"year":2012,"finding":"Loss of both Fgf4 and Fgf8 during late gastrulation results in failure to maintain paraxial mesoderm progenitors in the epiblast/tailbud, causing severe vertebral/rib defects, loss of Wnt3a and Brachyury expression, and cessation of somitogenesis after ~15–20 somites.","method":"Double conditional knockout (Cre/loxP) for Fgf4 and Fgf8, skeletal preparation, in situ hybridization for Wnt3a, Brachyury, and Notch pathway genes, BrdU/apoptosis analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1 — double conditional KO with defined axial elongation phenotype and molecular pathway dissection","pmids":["22954964"],"is_preprint":false},{"year":2013,"finding":"ARTD1/PARP1 PARylates Sox2, promoting Sox2 binding to the FGF4 enhancer and activating FGF4 expression during early reprogramming; exogenous FGF4 restores reprogramming capacity of Artd1-/- fibroblasts to wild-type levels, placing FGF4 downstream of ARTD1-Sox2 in the reprogramming pathway.","method":"Artd1 knockout fibroblasts, ARTD1 inhibitor treatment, ChIP for Sox2 at Fgf4 enhancer, exogenous FGF4 rescue of reprogramming efficiency","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP + KO + chemical inhibition + genetic rescue, multiple orthogonal methods","pmids":["23939864"],"is_preprint":false},{"year":2013,"finding":"FGF4 is the major limiting FGF in the preimplantation embryo controlling the ratio of primitive endoderm (PE) to epiblast (EPI) in the ICM; titrated exogenous FGF4 progressively increases PE proportions in a dose-dependent manner regardless of embryo genotype.","method":"Fgf4 hypomorphic/null mutant embryo series, exogenous FGF4 dose-response treatment, lineage marker analysis (GATA6/Nanog immunofluorescence)","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1 — genetic dosage series + dose-response protein addition with quantitative lineage readout","pmids":["24063807"],"is_preprint":false},{"year":2017,"finding":"FGF4 signaling (via FGFR and ERK) is required for primitive endoderm specification in the ICM; Klf5 acts as an upstream repressor of Fgf4, as Klf5 knockout embryos show markedly upregulated Fgf4 and skewed PE specification, which is reversed by FGFR/ERK inhibitors.","method":"Klf5 knockout embryo analysis, FGFR/ERK inhibitor treatment, immunofluorescence for PE/EPI markers, Klf5 overexpression embryos","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 — KO + pharmacological epistasis + OE with defined lineage phenotype, multiple approaches","pmids":["28870993"],"is_preprint":false},{"year":2017,"finding":"O-GlcNAcylation of PKCζ at its phosphorylation site inhibits PKCζ activation and consequently suppresses the FGF4-PKCζ-MEK-ERK1/2 signaling pathway in mouse embryonic stem cells, maintaining the undifferentiated state.","method":"O-GlcNAc inhibitor/enhancer treatment in ESCs, PKCζ mutagenesis, MEK/ERK phosphorylation western blot, FGF4 stimulation assays","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological manipulation of O-GlcNAc + PKCζ mutagenesis + signaling readout, single lab","pmids":["29249667"],"is_preprint":false},{"year":2018,"finding":"Sox2 expression level (more than Oct4) drives synergistic binding to the Fgf4 Sox/Oct composite motif; quantitative fluorescence correlation spectroscopy shows that binding affinity of Oct4/Sox2 heterodimer to the Fgf4 regulatory element is primarily determined by the Sox2 concentration, explaining how Sox2 fluctuations control epiblast/PE lineage segregation via FGF4.","method":"Fluorescence correlation spectroscopy (FCS) binding affinity measurements for Oct4 and Sox2 on Fgf4 Sox/Oct motif","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 1 — quantitative biophysical binding measurement, single lab","pmids":["29487166"],"is_preprint":false},{"year":2021,"finding":"FGF4 acts as a short-range paracrine signal mediating cell-cell communication that generates and maintains robust proportions of epiblast-like and primitive endoderm-like cells in mouse ESC cultures; FGF4 signaling enables autonomous re-establishment of cell-type proportions after perturbation.","method":"ESC culture with FGF4 signaling manipulation, cell-type proportion quantification, mathematical modeling, perturbation-restoration experiments","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 — defined signaling perturbation with quantitative population-level readout, single lab","pmids":["34651174"],"is_preprint":false},{"year":2022,"finding":"FGF4 protects the liver from NAFLD by activating hepatic FGFR4, which triggers a Ca2+/CaMKKβ-dependent AMPK-Caspase 6 signaling axis, leading to enhanced fatty acid oxidation and reduced hepatocellular apoptosis; hepatic Fgf4 deletion aggravates steatosis.","method":"Hepatic Fgf4 knockout mouse, recombinant FGF4 pharmacological treatment, FGFR4 blocking, AMPK and Caspase 6 pathway analysis, dietary NAFLD/NASH models","journal":"Hepatology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 1–2 — liver-specific KO + pharmacological gain-of-function + receptor-specific blockade + downstream signaling characterization, multiple orthogonal methods","pmids":["35152446"],"is_preprint":false},{"year":2023,"finding":"FGF4 inhibits hepatocyte ferroptosis in autoimmune hepatitis by upregulating CISD3 and activating Nrf2/HO-1 signaling; Fgf4 depletion increases lipid peroxidation and iron accumulation, while recombinant FGF4 rescues ferroptotic markers (xCT, GPX4) in an erastin-induced model.","method":"Hepatic Fgf4 knockout mouse, recombinant FGF4 treatment, CISD3 overexpression/knockdown, Erastin-induced ferroptosis model in AML12 cells, TUNEL/lipid peroxidation assays","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — KO + protein rescue + downstream target manipulation with defined ferroptosis readouts, single lab","pmids":["36702076"],"is_preprint":false},{"year":2024,"finding":"Hepatic FGF4 is a direct transcriptional target of FXR that acts as a paracrine signal to downregulate bile acid synthesis genes Cyp7a1 and Cyp8b1 via an intracellular FGFR4-LRH-1 signaling node; this pathway functions upstream of the peripheral FXR-FGF15/19 pathway as a first-line checkpoint for intrahepatic bile acid homeostasis.","method":"Hepatic Fgf4 conditional knockout, FXR chromatin immunoprecipitation, FGFR4 signaling analysis, LRH-1 pathway analysis, cholestatic mouse models, recombinant FGF4 treatment","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1–2 — direct FXR-ChIP identification of Fgf4 as target + conditional KO + receptor/downstream pathway dissection + pharmacological rescue, multiple orthogonal methods","pmids":["39393353"],"is_preprint":false}],"current_model":"FGF4 is a secreted heparan-sulfate-binding growth factor whose transcription in pluripotent/embryonic cells is driven by a Sox2/Oct-3 ternary complex on a downstream enhancer (regulated by KDM7A demethylation and ARTD1-mediated Sox2 PARylation); it signals through FGF receptors (primarily FGFR2 and FGFR4) and heparan sulfate proteoglycans to activate PKCζ-MEK-ERK1/2 and AMPK-Caspase 6 cascades, functioning as a critical paracrine/autocrine mitogen and differentiation signal in trophoblast stem cell maintenance, ICM primitive endoderm/epiblast proportioning, limb bud mesenchyme survival (where it is functionally redundant with FGF8), axial elongation, tooth and cardiac valve morphogenesis, bile acid homeostasis via hepatic FGFR4-LRH-1 signaling, and protection of liver and germ cells from stress-induced cell death."},"narrative":{"teleology":[{"year":1987,"claim":"Identification of FGF4 (hst) as an oncogene encoding a 206-aa protein sufficient for NIH3T3 transformation established the gene as a growth-promoting factor.","evidence":"cDNA cloning and expression-vector transfection transformation assay in NIH3T3 cells","pmids":["2953031"],"confidence":"High","gaps":["No receptor or signaling pathway identified","Endogenous expression context unknown"]},{"year":1991,"claim":"Demonstrating that FGF4 transforming activity requires secretion and extracellular receptor engagement resolved whether FGF4 acts intracellularly or as a classical secreted ligand; concurrent identification of Oct4 binding at the FGF4 enhancer linked its expression to pluripotency.","evidence":"Signal-peptide deletion, KDEL-retention mutants, neutralizing antibodies, and suramin reversal in NIH3T3 assays; CAT reporter and EMSA in EC/ES cells","pmids":["1990270","1655808","1723621"],"confidence":"High","gaps":["Specific FGF receptor identity not determined","Sox2 co-requirement not yet recognized"]},{"year":1992,"claim":"Establishing heparan sulfate proteoglycan dependence for FGF4 activity defined a co-receptor requirement essential for signaling competence.","evidence":"Chlorate inhibition of sulfation abolishes FGF4 activity on MM14 myoblasts; heparin rescue restores signaling","pmids":["1379245"],"confidence":"High","gaps":["Specific HSPG species not identified","In vivo relevance of HSPG requirement untested"]},{"year":1994,"claim":"Multiple studies revealed FGF4's diverse paracrine roles — stimulating dental cell proliferation, promoting ICM parietal endoderm differentiation, driving angiogenesis, and increasing megakaryocyte/platelet production — extending its biology beyond simple oncogenic transformation.","evidence":"Recombinant FGF4 addition to dental tissues, isolated ICM, CAM/cornea angiogenesis assays, and adenoviral gene transfer in mice","pmids":["7848830","7925026","7520355","7809043"],"confidence":"Medium","gaps":["Receptor specificity for each tissue context unknown","Dose-response relationships not established","In vivo genetic confirmation lacking for most contexts"]},{"year":1995,"claim":"The Sox2/Oct-3 ternary complex mechanism was defined, and Fgf4-knockout lethality proved FGF4 is an essential embryonic mitogen whose loss causes ICM proliferation failure rescuable by exogenous protein.","evidence":"Ternary complex reconstitution on Fgf4 enhancer DNA with EMSA/reporter assays; homozygous Fgf4 gene targeting with embryo culture and FGF4 protein rescue","pmids":["7590241","7809630"],"confidence":"High","gaps":["Downstream signaling pathway from FGFR in ICM not characterized","Relative contributions of mitogenic vs. differentiation functions not separated"]},{"year":1998,"claim":"FGF4 was shown to be necessary and sufficient for trophoblast stem cell self-renewal, and to antagonize BMP-induced apoptosis in limb mesenchyme, establishing it as a key survival and stemness factor.","evidence":"TS cell derivation/maintenance with FGF4 addition/withdrawal and in vivo chimera analysis; FGF4 bead implantation in chick limb buds blocking BMP4-induced apoptosis","pmids":["9851926","9507096"],"confidence":"High","gaps":["Identity of downstream FGF receptor in trophoblast stem cells not defined","Mechanism of BMP antagonism (convergent signaling vs. transcriptional) not resolved"]},{"year":2000,"claim":"Conditional AER-specific Fgf4 knockout yielded normal limbs, overturning the assumed essential role of FGF4 alone in limb patterning and revealing functional redundancy among AER-FGFs.","evidence":"Cre/loxP conditional knockout in two independent studies with limb morphology and in situ hybridization analysis","pmids":["10662638","10802662"],"confidence":"High","gaps":["Which AER-FGF combination is minimally sufficient not yet tested","Quantitative contribution of FGF4 vs. FGF8 undetermined"]},{"year":2002,"claim":"FGF4 was identified as a direct transcriptional target of LEF1/Wnt signaling that mediates epithelial-mesenchymal cross-talk in tooth morphogenesis, broadening the upstream regulatory landscape beyond Oct4/Sox2.","evidence":"ChIP/reporter for LEF1 on Fgf4 promoter; FGF4-bead rescue of Lef1-null tooth arrest","pmids":["12502739"],"confidence":"High","gaps":["Whether Wnt-dependent Fgf4 regulation operates in non-dental tissues unknown","Mechanism of FGF4-induced Shh in mesenchyme not characterized"]},{"year":2004,"claim":"Double Fgf4/Fgf8 conditional knockout proved that FGF4 and FGF8 are functionally redundant in sustaining limb mesenchyme survival and Shh expression, resolving why single Fgf4 loss had no limb phenotype.","evidence":"Double conditional knockout with apoptosis analysis and in situ hybridization for Shh and Fgf10","pmids":["15328019"],"confidence":"High","gaps":["Whether FGF4/FGF8 redundancy extends to signaling pathway level or is purely quantitative not resolved"]},{"year":2005,"claim":"Allele-swap experiments demonstrated full functional interchangeability of FGF4 and FGF8 in limb skeletal development, establishing molecular equivalence at the receptor-activation level.","evidence":"Conditional Fgf4 gain-of-function allele activated simultaneously with Fgf8 inactivation via Cre; skeletal preparation analysis","pmids":["16308330"],"confidence":"High","gaps":["Whether FGF4 and FGF8 activate identical downstream intracellular cascades not tested biochemically"]},{"year":2010,"claim":"KDM7A was shown to directly activate FGF4 transcription by removing repressive H3K9me2/H3K27me2 marks, linking chromatin state to FGF4 expression and neural differentiation.","evidence":"KDM7A knockdown in mouse ESCs with ChIP at Fgf4 locus; rescue with wild-type but not catalytic-dead KDM7A","pmids":["20084082"],"confidence":"High","gaps":["Whether KDM7A acts at the Fgf4 enhancer or promoter specifically not mapped at nucleosome resolution","Interaction with Sox2/Oct4 complex not tested"]},{"year":2012,"claim":"Double Fgf4/Fgf8 loss during late gastrulation revealed that these FGFs maintain paraxial mesoderm progenitors and are required for axial elongation beyond ~15–20 somites.","evidence":"Double conditional knockout with skeletal preparation and in situ hybridization for Wnt3a, Brachyury, and Notch pathway genes","pmids":["22954964"],"confidence":"High","gaps":["Individual contribution of FGF4 vs. FGF8 to tailbud progenitor maintenance not separable"]},{"year":2013,"claim":"Two advances refined FGF4's role in preimplantation development: ARTD1-mediated PARylation of Sox2 was shown to promote Sox2 occupancy at the FGF4 enhancer during reprogramming, and FGF4 dosage was identified as the primary determinant of primitive endoderm-to-epiblast ratio in the ICM.","evidence":"Artd1 KO fibroblasts with ChIP and FGF4 rescue of reprogramming; Fgf4 hypomorphic/null allelic series with quantitative lineage marker analysis","pmids":["23939864","24063807"],"confidence":"High","gaps":["Whether PARylation of Sox2 is constitutive or signal-regulated not known","Identity of the FGFR mediating PE specification not confirmed"]},{"year":2017,"claim":"Downstream signaling was mapped: FGF4 activates a PKCζ–MEK–ERK1/2 cascade in ESCs (modulated by O-GlcNAcylation of PKCζ), and Klf5 was identified as an upstream transcriptional repressor of Fgf4 controlling PE specification.","evidence":"O-GlcNAc inhibitor/enhancer treatment with PKCζ mutagenesis and ERK phosphorylation readout; Klf5 KO embryos with FGFR/ERK inhibitor rescue","pmids":["29249667","28870993"],"confidence":"High","gaps":["Whether PKCζ–ERK axis is the sole pathway downstream of FGFR in ESCs not tested","Direct Klf5 binding to Fgf4 promoter not shown"]},{"year":2022,"claim":"A hepatoprotective function was uncovered: hepatic FGF4 signals through FGFR4 to activate a Ca²⁺/CaMKKβ–AMPK–Caspase 6 axis that promotes fatty acid oxidation and reduces apoptosis in NAFLD.","evidence":"Hepatic Fgf4 conditional knockout, recombinant FGF4 treatment, FGFR4 blockade, and AMPK/Caspase 6 pathway analysis in dietary NAFLD/NASH models","pmids":["35152446"],"confidence":"High","gaps":["Whether FGF4 hepatoprotection is relevant in human NAFLD not tested","Source cells producing hepatic FGF4 not fully characterized"]},{"year":2024,"claim":"Hepatic FGF4 was identified as a direct FXR transcriptional target that represses bile acid synthesis via an FGFR4–LRH-1 signaling node, functioning as an intrahepatic first-line checkpoint upstream of the peripheral FGF15/19 pathway.","evidence":"FXR ChIP at Fgf4, hepatic Fgf4 conditional KO, FGFR4/LRH-1 pathway analysis, cholestatic mouse models, recombinant FGF4 rescue","pmids":["39393353"],"confidence":"High","gaps":["Whether human hepatocytes produce functionally equivalent FGF4 levels not demonstrated","Relative quantitative contribution of FGF4 vs. FGF15/19 axis under physiological conditions unknown"]},{"year":null,"claim":"Key unresolved questions include: which FGFRs mediate FGF4 signaling in trophoblast stem cells and in PE specification; whether the PKCζ–ERK and AMPK–Caspase 6 cascades represent tissue-specific or general FGF4 signaling modes; and whether hepatic FGF4 functions are conserved in human liver physiology and disease.","evidence":"","pmids":[],"confidence":"Low","gaps":["Receptor identity for FGF4 in trophoblast stem cells and PE specification not confirmed","Structural basis for FGF4/FGF8 interchangeability unknown","Human translational relevance of hepatic FGF4 functions not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[1,5,6,11,14,31,36,38]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[15,31,36]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[1,2,11,14,31]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,4,33,36,38]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[11,14,16,18,25,27,29,31]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[36,38]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[10,21,28,30,38]}],"complexes":[],"partners":["FGFR2","FGFR4","SOX2","POU5F1","LEF1","KDM7A","ARTD1"],"other_free_text":[]},"mechanistic_narrative":"FGF4 is a secreted, heparan-sulfate-dependent fibroblast growth factor that functions as a paracrine and autocrine mitogen and differentiation signal across multiple developmental and metabolic contexts. Its transcription in pluripotent cells is driven by a Sox2/Oct-3 ternary complex on a downstream enhancer, with additional regulation by LEF1/Wnt signaling in dental epithelium and FXR in hepatocytes; epigenetic activation requires KDM7A-mediated removal of H3K9me2/H3K27me2, and Sox2 binding is promoted by ARTD1-dependent PARylation [PMID:7590241, PMID:12502739, PMID:20084082, PMID:23939864, PMID:39393353]. FGF4 signals through FGFR2 and FGFR4 to activate PKCζ–MEK–ERK1/2 and AMPK–Caspase 6 cascades, and is the principal FGF controlling the ratio of primitive endoderm to epiblast in the inner cell mass, maintaining trophoblast stem cells, and — redundantly with FGF8 — sustaining limb bud mesenchyme survival and axial elongation [PMID:24063807, PMID:9851926, PMID:15328019, PMID:22954964, PMID:29249667, PMID:35152446]. In postnatal tissues, hepatic FGF4 acts through an FGFR4–LRH-1 signaling node to repress bile acid synthesis genes Cyp7a1 and Cyp8b1 as a first-line intrahepatic checkpoint, protects hepatocytes from NAFLD-associated lipotoxicity and ferroptosis, and shields male germ cells from heat-stress apoptosis via MAPK activation [PMID:39393353, PMID:35152446, PMID:36702076, PMID:14980503]."},"prefetch_data":{"uniprot":{"accession":"P08620","full_name":"Fibroblast growth factor 4","aliases":["Heparin secretory-transforming protein 1","HST","HST-1","HSTF-1","Heparin-binding growth factor 4","HBGF-4","Transforming protein KS3"],"length_aa":206,"mass_kda":22.0,"function":"Plays an important role in the regulation of embryonic development, cell proliferation, and cell differentiation. Required for normal limb and cardiac valve development during embryogenesis. May play a role in embryonic molar tooth bud development via inducing the expression of MSX1, MSX2 and MSX1-mediated expression of SDC1 in dental mesenchyme cells (By similarity)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P08620/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FGF4","classification":"Not Classified","n_dependent_lines":14,"n_total_lines":1208,"dependency_fraction":0.011589403973509934},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FGF4","total_profiled":1310},"omim":[{"mim_id":"621260","title":"SHORT-RIB THORACIC DYSPLASIA 22 WITHOUT POLYDACTYLY; SRTD22","url":"https://www.omim.org/entry/621260"},{"mim_id":"619640","title":"LYSINE DEMETHYLASE 7A; KDM7A","url":"https://www.omim.org/entry/619640"},{"mim_id":"615719","title":"TCL1 UPSTREAM NEURAL DIFFERENTIATION-ASSOCIATED RNA; TUNAR","url":"https://www.omim.org/entry/615719"},{"mim_id":"611539","title":"FORKHEAD BOX D3; FOXD3","url":"https://www.omim.org/entry/611539"},{"mim_id":"609675","title":"SCLEROSTIN DOMAIN-CONTAINING PROTEIN 1; SOSTDC1","url":"https://www.omim.org/entry/609675"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Not detected","tissue_distribution":"Not detected","driving_tissues":[],"url":"https://www.proteinatlas.org/search/FGF4"},"hgnc":{"alias_symbol":["K-FGF","HBGF-4","HST","HST-1","KFGF"],"prev_symbol":["HSTF1"]},"alphafold":{"accession":"P08620","domains":[{"cath_id":"2.80.10.50","chopping":"81-204","consensus_level":"high","plddt":97.2406,"start":81,"end":204}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P08620","model_url":"https://alphafold.ebi.ac.uk/files/AF-P08620-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P08620-F1-predicted_aligned_error_v6.png","plddt_mean":81.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FGF4","jax_strain_url":"https://www.jax.org/strain/search?query=FGF4"},"sequence":{"accession":"P08620","fasta_url":"https://rest.uniprot.org/uniprotkb/P08620.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P08620/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P08620"}},"corpus_meta":[{"pmid":"9851926","id":"PMC_9851926","title":"Promotion of trophoblast stem cell proliferation by FGF4.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9851926","citation_count":1135,"is_preprint":false},{"pmid":"1618140","id":"PMC_1618140","title":"Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse.","date":"1992","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1618140","citation_count":621,"is_preprint":false},{"pmid":"7590241","id":"PMC_7590241","title":"Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.","date":"1995","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7590241","citation_count":607,"is_preprint":false},{"pmid":"7809630","id":"PMC_7809630","title":"Requirement of FGF-4 for postimplantation mouse development.","date":"1995","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/7809630","citation_count":605,"is_preprint":false},{"pmid":"10524628","id":"PMC_10524628","title":"Signal relay by BMP antagonism controls the SHH/FGF4 feedback loop in vertebrate limb buds.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10524628","citation_count":378,"is_preprint":false},{"pmid":"7848830","id":"PMC_7848830","title":"Evidence for the role of the enamel knot as a control center in mammalian tooth cusp formation: non-dividing cells express growth stimulating Fgf-4 gene.","date":"1994","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/7848830","citation_count":343,"is_preprint":false},{"pmid":"2953031","id":"PMC_2953031","title":"cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity.","date":"1987","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2953031","citation_count":328,"is_preprint":false},{"pmid":"19608863","id":"PMC_19608863","title":"An expressed fgf4 retrogene is associated with breed-defining chondrodysplasia in domestic dogs.","date":"2009","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/19608863","citation_count":252,"is_preprint":false},{"pmid":"10802662","id":"PMC_10802662","title":"Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10802662","citation_count":242,"is_preprint":false},{"pmid":"1379245","id":"PMC_1379245","title":"Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate.","date":"1992","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1379245","citation_count":223,"is_preprint":false},{"pmid":"12502739","id":"PMC_12502739","title":"FGF4, a direct target of LEF1 and Wnt signaling, can rescue the arrest of tooth organogenesis in Lef1(-/-) mice.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12502739","citation_count":204,"is_preprint":false},{"pmid":"2474139","id":"PMC_2474139","title":"Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas.","date":"1989","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2474139","citation_count":193,"is_preprint":false},{"pmid":"9927596","id":"PMC_9927596","title":"Sequential roles for Fgf4, En1 and Fgf8 in specification and regionalisation of the midbrain.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9927596","citation_count":181,"is_preprint":false},{"pmid":"1706218","id":"PMC_1706218","title":"Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors.","date":"1991","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/1706218","citation_count":179,"is_preprint":false},{"pmid":"2529025","id":"PMC_2529025","title":"High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.","date":"1989","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/2529025","citation_count":178,"is_preprint":false},{"pmid":"8812122","id":"PMC_8812122","title":"Combined BMP-2 and FGF-4, but neither factor alone, induces cardiogenesis in non-precardiac embryonic mesoderm.","date":"1996","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/8812122","citation_count":166,"is_preprint":false},{"pmid":"15328019","id":"PMC_15328019","title":"The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15328019","citation_count":158,"is_preprint":false},{"pmid":"2483371","id":"PMC_2483371","title":"Mesoderm-inducing properties of INT-2 and kFGF: two oncogene-encoded growth factors related to FGF.","date":"1989","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/2483371","citation_count":156,"is_preprint":false},{"pmid":"17906623","id":"PMC_17906623","title":"Duplication of FGF3, FGF4, FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs.","date":"2007","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17906623","citation_count":156,"is_preprint":false},{"pmid":"7925026","id":"PMC_7925026","title":"Expression and function of FGF-4 in peri-implantation development in mouse embryos.","date":"1994","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7925026","citation_count":153,"is_preprint":false},{"pmid":"12086472","id":"PMC_12086472","title":"Fgf4 positively regulates scleraxis and tenascin expression in chick limb tendons.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12086472","citation_count":145,"is_preprint":false},{"pmid":"3283658","id":"PMC_3283658","title":"Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma.","date":"1988","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/3283658","citation_count":145,"is_preprint":false},{"pmid":"22890726","id":"PMC_22890726","title":"FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma.","date":"2013","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/22890726","citation_count":126,"is_preprint":false},{"pmid":"11923208","id":"PMC_11923208","title":"Early embryonic expression of FGF4/6/9 gene and its role in the induction of mesenchyme and notochord in Ciona savignyi embryos.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11923208","citation_count":126,"is_preprint":false},{"pmid":"12792807","id":"PMC_12792807","title":"Evolutionary conservation of CCND1-ORAOV1-FGF19-FGF4 locus from zebrafish to human.","date":"2003","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12792807","citation_count":116,"is_preprint":false},{"pmid":"29073074","id":"PMC_29073074","title":"FGF4 retrogene on CFA12 is responsible for chondrodystrophy and intervertebral disc disease in dogs.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29073074","citation_count":110,"is_preprint":false},{"pmid":"24063807","id":"PMC_24063807","title":"FGF4 is a limiting factor controlling the proportions of primitive endoderm and epiblast in the ICM of the mouse blastocyst.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24063807","citation_count":110,"is_preprint":false},{"pmid":"32883967","id":"PMC_32883967","title":"In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32883967","citation_count":106,"is_preprint":false},{"pmid":"10662638","id":"PMC_10662638","title":"Normal limb development in conditional mutants of Fgf4.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10662638","citation_count":106,"is_preprint":false},{"pmid":"12748966","id":"PMC_12748966","title":"Paracrine action of FGF4 during periimplantation development maintains trophectoderm and primitive endoderm.","date":"2003","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/12748966","citation_count":104,"is_preprint":false},{"pmid":"22954964","id":"PMC_22954964","title":"Signaling by FGF4 and FGF8 is required for axial elongation of the mouse embryo.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22954964","citation_count":95,"is_preprint":false},{"pmid":"20084082","id":"PMC_20084082","title":"Dual-specificity histone demethylase KIAA1718 (KDM7A) regulates neural differentiation through FGF4.","date":"2010","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/20084082","citation_count":93,"is_preprint":false},{"pmid":"19277121","id":"PMC_19277121","title":"FGF4 and retinoic acid direct differentiation of hESCs into PDX1-expressing foregut endoderm in a time- and concentration-dependent manner.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19277121","citation_count":86,"is_preprint":false},{"pmid":"2188089","id":"PMC_2188089","title":"Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells.","date":"1990","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2188089","citation_count":86,"is_preprint":false},{"pmid":"16308330","id":"PMC_16308330","title":"Increasing Fgf4 expression in the mouse limb bud causes polysyndactyly and rescues the skeletal defects that result from loss of Fgf8 function.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16308330","citation_count":80,"is_preprint":false},{"pmid":"3133332","id":"PMC_3133332","title":"Coamplification of the hst-1 and int-2 genes in human cancers.","date":"1988","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/3133332","citation_count":79,"is_preprint":false},{"pmid":"9507096","id":"PMC_9507096","title":"Antagonistic effects of FGF4 on BMP induction of apoptosis and chondrogenesis in the chick limb bud.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9507096","citation_count":78,"is_preprint":false},{"pmid":"2780052","id":"PMC_2780052","title":"Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells.","date":"1989","source":"Oncogene research","url":"https://pubmed.ncbi.nlm.nih.gov/2780052","citation_count":69,"is_preprint":false},{"pmid":"35870977","id":"PMC_35870977","title":"Exosomes from mmu_circ_0001052-modified adipose-derived stem cells promote angiogenesis of DFU via miR-106a-5p and FGF4/p38MAPK pathway.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35870977","citation_count":68,"is_preprint":false},{"pmid":"16804893","id":"PMC_16804893","title":"FGF-4 signaling is involved in mir-206 expression in developing somites of chicken embryos.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16804893","citation_count":65,"is_preprint":false},{"pmid":"15671174","id":"PMC_15671174","title":"Heparan 2-O-sulfotransferase, hst-2, is essential for normal cell migration in Caenorhabditis elegans.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15671174","citation_count":63,"is_preprint":false},{"pmid":"12798286","id":"PMC_12798286","title":"Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12798286","citation_count":62,"is_preprint":false},{"pmid":"35152446","id":"PMC_35152446","title":"FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP-activated protein kinase-Caspase 6 signal axis.","date":"2022","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/35152446","citation_count":55,"is_preprint":false},{"pmid":"2272506","id":"PMC_2272506","title":"Hst-3: an X-linked hybrid sterility gene.","date":"1990","source":"Genetical research","url":"https://pubmed.ncbi.nlm.nih.gov/2272506","citation_count":54,"is_preprint":false},{"pmid":"7601570","id":"PMC_7601570","title":"Inhibition of cis-diamminedichloroplatinum (II)-induced DNA interstrand cross-link removal by 7-ethyl-10-hydroxy-camptothecin in HST-1 human squamous-carcinoma cells.","date":"1995","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7601570","citation_count":53,"is_preprint":false},{"pmid":"24445281","id":"PMC_24445281","title":"Paracrine effects of embryo-derived FGF4 and BMP4 during pig trophoblast elongation.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24445281","citation_count":52,"is_preprint":false},{"pmid":"25329002","id":"PMC_25329002","title":"Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.","date":"2014","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25329002","citation_count":52,"is_preprint":false},{"pmid":"16723380","id":"PMC_16723380","title":"FGF-4 regulates neural progenitor cell proliferation and neuronal differentiation.","date":"2006","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/16723380","citation_count":51,"is_preprint":false},{"pmid":"1990270","id":"PMC_1990270","title":"The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway.","date":"1991","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1990270","citation_count":50,"is_preprint":false},{"pmid":"9626498","id":"PMC_9626498","title":"Crouzon-like craniofacial dysmorphology in the mouse is caused by an insertional mutation at the Fgf3/Fgf4 locus.","date":"1998","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9626498","citation_count":49,"is_preprint":false},{"pmid":"1723621","id":"PMC_1723621","title":"Octamer-dependent regulation of the kFGF gene in embryonal carcinoma and embryonic stem cells.","date":"1991","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/1723621","citation_count":48,"is_preprint":false},{"pmid":"3136110","id":"PMC_3136110","title":"Amplification of the hst-1 gene in human esophageal carcinomas.","date":"1988","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/3136110","citation_count":48,"is_preprint":false},{"pmid":"11319857","id":"PMC_11319857","title":"Misexpression of Fgf-4 in the chick limb inhibits myogenesis by down-regulating Frek expression.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11319857","citation_count":46,"is_preprint":false},{"pmid":"27677589","id":"PMC_27677589","title":"FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27677589","citation_count":44,"is_preprint":false},{"pmid":"39393353","id":"PMC_39393353","title":"Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress.","date":"2024","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/39393353","citation_count":43,"is_preprint":false},{"pmid":"18792115","id":"PMC_18792115","title":"Pleiotropic function of FGF-4: its role in development and stem cells.","date":"2009","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/18792115","citation_count":43,"is_preprint":false},{"pmid":"2895649","id":"PMC_2895649","title":"Cloned hst gene from normal human leukocyte DNA transforms NIH3T3 cells.","date":"1988","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2895649","citation_count":43,"is_preprint":false},{"pmid":"7999365","id":"PMC_7999365","title":"Function of FGF-4 in limb development.","date":"1994","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/7999365","citation_count":38,"is_preprint":false},{"pmid":"11222686","id":"PMC_11222686","title":"Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.","date":"2001","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/11222686","citation_count":36,"is_preprint":false},{"pmid":"9740330","id":"PMC_9740330","title":"Effects of differentiation on the transcriptional regulation of the FGF-4 gene: critical roles played by a distal enhancer.","date":"1998","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/9740330","citation_count":36,"is_preprint":false},{"pmid":"25515008","id":"PMC_25515008","title":"Establishment of a primed pluripotent epiblast stem cell in FGF4-based conditions.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25515008","citation_count":35,"is_preprint":false},{"pmid":"8621231","id":"PMC_8621231","title":"Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.","date":"1996","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8621231","citation_count":35,"is_preprint":false},{"pmid":"9509064","id":"PMC_9509064","title":"Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.","date":"1998","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9509064","citation_count":34,"is_preprint":false},{"pmid":"3040649","id":"PMC_3040649","title":"Identification of transforming genes as hst in DNA samples from two human hepatocellular carcinomas.","date":"1987","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/3040649","citation_count":34,"is_preprint":false},{"pmid":"8608216","id":"PMC_8608216","title":"Effects of fibroblast growth factor-4 (k-FGF) on long-term cultures of human bone marrow cells.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8608216","citation_count":33,"is_preprint":false},{"pmid":"7520355","id":"PMC_7520355","title":"Angiogenic activity of the recombinant hst-1 protein.","date":"1994","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/7520355","citation_count":31,"is_preprint":false},{"pmid":"25685159","id":"PMC_25685159","title":"Mesenchymal Stem Cells Pretreated with HGF and FGF4 Can Reduce Liver Fibrosis in Mice.","date":"2015","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/25685159","citation_count":31,"is_preprint":false},{"pmid":"36702076","id":"PMC_36702076","title":"FGF4 improves hepatocytes ferroptosis in autoimmune hepatitis mice via activation of CISD3.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36702076","citation_count":31,"is_preprint":false},{"pmid":"34651174","id":"PMC_34651174","title":"Cell-cell communication through FGF4 generates and maintains robust proportions of differentiated cell types in embryonic stem cells.","date":"2021","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34651174","citation_count":31,"is_preprint":false},{"pmid":"23939864","id":"PMC_23939864","title":"Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via Sox2 ADP-ribosylation.","date":"2013","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/23939864","citation_count":29,"is_preprint":false},{"pmid":"7929190","id":"PMC_7929190","title":"An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7929190","citation_count":29,"is_preprint":false},{"pmid":"7809043","id":"PMC_7809043","title":"Adenovirus-mediated transfer of the HST-1 (FGF4) gene induces increased levels of platelet count in vivo.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7809043","citation_count":29,"is_preprint":false},{"pmid":"1549352","id":"PMC_1549352","title":"Human hst-2 (FGF-6) oncogene: cDNA cloning and characterization.","date":"1992","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1549352","citation_count":28,"is_preprint":false},{"pmid":"24535868","id":"PMC_24535868","title":"FGF4 and HGF promote differentiation of mouse bone marrow mesenchymal stem cells into hepatocytes via the MAPK pathway.","date":"2014","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/24535868","citation_count":28,"is_preprint":false},{"pmid":"7763013","id":"PMC_7763013","title":"Sequence-dependent modulation of anticancer drug activities by 7-ethyl-10-hydroxycamptothecin in an HST-1 human squamous carcinoma cell line.","date":"1995","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7763013","citation_count":28,"is_preprint":false},{"pmid":"9798677","id":"PMC_9798677","title":"FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9798677","citation_count":28,"is_preprint":false},{"pmid":"14980503","id":"PMC_14980503","title":"HST-1/FGF-4 protects male germ cells from apoptosis under heat-stress condition.","date":"2004","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/14980503","citation_count":27,"is_preprint":false},{"pmid":"7635948","id":"PMC_7635948","title":"Effective prevention of thrombocytopenia in mice using adenovirus-mediated transfer of HST-1 (FGF-4) gene.","date":"1995","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/7635948","citation_count":27,"is_preprint":false},{"pmid":"7642715","id":"PMC_7642715","title":"Hst-1 (FGF-4) antisense oligonucleotides block murine limb development.","date":"1995","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7642715","citation_count":26,"is_preprint":false},{"pmid":"3030292","id":"PMC_3030292","title":"Genomic clone of hst with transforming activity from a patient with acute leukemia.","date":"1987","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/3030292","citation_count":26,"is_preprint":false},{"pmid":"30887595","id":"PMC_30887595","title":"Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.","date":"2019","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30887595","citation_count":25,"is_preprint":false},{"pmid":"10786811","id":"PMC_10786811","title":"FGF4 and INT2 oncogenes are amplified and expressed in Kaposi's sarcoma.","date":"2000","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/10786811","citation_count":25,"is_preprint":false},{"pmid":"26230325","id":"PMC_26230325","title":"Intestinal Commitment and Maturation of Human Pluripotent Stem Cells Is Independent of Exogenous FGF4 and R-spondin1.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26230325","citation_count":25,"is_preprint":false},{"pmid":"26828265","id":"PMC_26828265","title":"The oncoprotein HBXIP up-regulates FGF4 through activating transcriptional factor Sp1 to promote the migration of breast cancer cells.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26828265","citation_count":25,"is_preprint":false},{"pmid":"29487166","id":"PMC_29487166","title":"Dynamic changes in Sox2 spatio-temporal expression promote the second cell fate decision through Fgf4/Fgfr2 signaling in preimplantation mouse embryos.","date":"2018","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/29487166","citation_count":24,"is_preprint":false},{"pmid":"10954851","id":"PMC_10954851","title":"Effects of three Sp1 motifs on the transcription of the FGF-4 gene.","date":"2000","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/10954851","citation_count":23,"is_preprint":false},{"pmid":"11840335","id":"PMC_11840335","title":"HST-1/FGF-4 gene activation induces spermatogenesis and prevents adriamycin-induced testicular toxicity.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11840335","citation_count":23,"is_preprint":false},{"pmid":"1655808","id":"PMC_1655808","title":"Cell transformation by kFGF requires secretion but not glycosylation.","date":"1991","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1655808","citation_count":22,"is_preprint":false},{"pmid":"29249667","id":"PMC_29249667","title":"O-GlcNAc on PKCζ Inhibits the FGF4-PKCζ-MEK-ERK1/2 Pathway via Inhibition of PKCζ Phosphorylation in Mouse Embryonic Stem Cells.","date":"2017","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29249667","citation_count":22,"is_preprint":false},{"pmid":"27683262","id":"PMC_27683262","title":"Hypoxic Stress Forces Irreversible Differentiation of a Majority of Mouse Trophoblast Stem Cells Despite FGF4.","date":"2016","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/27683262","citation_count":22,"is_preprint":false},{"pmid":"28870993","id":"PMC_28870993","title":"Klf5 maintains the balance of primitive endoderm versus epiblast specification during mouse embryonic development by suppression of Fgf4.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28870993","citation_count":22,"is_preprint":false},{"pmid":"8143931","id":"PMC_8143931","title":"All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas.","date":"1994","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/8143931","citation_count":22,"is_preprint":false},{"pmid":"15942670","id":"PMC_15942670","title":"Comparative genomics on mammalian Fgf3-Fgf4 locus.","date":"2005","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/15942670","citation_count":21,"is_preprint":false},{"pmid":"10694418","id":"PMC_10694418","title":"Influence of FGF4 on digit morphogenesis during limb development in the mouse.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10694418","citation_count":21,"is_preprint":false},{"pmid":"10511109","id":"PMC_10511109","title":"Anabolic effect of aminoterminally truncated fibroblast growth factor 4 (FGF4) on bone.","date":"1999","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/10511109","citation_count":21,"is_preprint":false},{"pmid":"8649829","id":"PMC_8649829","title":"Induction of expression of growth-related genes by FGF-4 in mouse fibroblasts.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8649829","citation_count":20,"is_preprint":false},{"pmid":"35205370","id":"PMC_35205370","title":"The Effects of FGF4 Retrogenes on Canine Morphology.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35205370","citation_count":19,"is_preprint":false},{"pmid":"1868036","id":"PMC_1868036","title":"Localization of the HST/FGFK gene with regard to 11q13 chromosomal breakpoint and fragile site.","date":"1991","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/1868036","citation_count":19,"is_preprint":false},{"pmid":"1375717","id":"PMC_1375717","title":"Angiogenic activity of the K-fgf/hst oncogene in neural transplants.","date":"1992","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1375717","citation_count":18,"is_preprint":false},{"pmid":"8143853","id":"PMC_8143853","title":"Regulatory sequences required for hst-1 expression in embryonal carcinoma cells.","date":"1994","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8143853","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46981,"output_tokens":8876,"usd":0.137042},"stage2":{"model":"claude-opus-4-6","input_tokens":12746,"output_tokens":4136,"usd":0.250695},"total_usd":0.387737,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"The hst (FGF4) gene encodes a 206 amino acid open reading frame that is sufficient for transforming activity when expressed in NIH3T3 cells via an SV40 promoter-containing vector.\",\n      \"method\": \"cDNA cloning, expression vector transfection, NIH3T3 transformation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro transformation assay with defined coding sequence, foundational paper\",\n      \"pmids\": [\"2953031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"FGF4 (K-fgf/hst) transforms cells through an autocrine mechanism that requires secretion and extracellular receptor activation at the cell surface; deletion of the signal peptide or retention of the protein in the ER (KDEL motif) abolishes transforming activity, and anti-FGF4 neutralizing antibodies reverse the transformed phenotype.\",\n      \"method\": \"Signal peptide deletion mutants, KDEL retention mutants, NIH3T3 focus formation assay, neutralizing antibody treatment, soft-agar and serum-free growth assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of signal peptide + KDEL retention + antibody reversal, multiple orthogonal methods in one study\",\n      \"pmids\": [\"1990270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Cell transformation by kFGF requires secretion but not glycosylation; cytoplasmic or ER-retained kFGF mutants fail to transform NIH3T3 cells, and suramin reverses transformation by both glycosylated and unglycosylated secreted forms.\",\n      \"method\": \"Glycosylation site mutagenesis, KDEL retention mutant, NIH3T3 transformation assay, suramin inhibition\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis plus pharmacological inhibition, replicated conclusion from independent lab\",\n      \"pmids\": [\"1655808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"The kFGF/FGF4 gene enhancer contains an octamer-binding sequence that binds Oct1 and Oct4 (but not Oct1 alone after differentiation), indicating that Oct4 positively regulates FGF4 transcription in undifferentiated embryonal carcinoma and embryonic stem cells.\",\n      \"method\": \"CAT reporter assays, electrophoretic mobility shift assay (EMSA), transfection into EC/ES cells\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay + EMSA, single lab\",\n      \"pmids\": [\"1723621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"FGF4 signaling for myoblast repression requires heparan sulfate proteoglycans (HSPG); chlorate-mediated inhibition of glycosaminoglycan sulfation abrogates FGF4 biological activity, which is restored by heparin or sodium sulfate co-addition.\",\n      \"method\": \"Chlorate treatment of MM14 myoblasts, heparitinase treatment, FGF binding assay, differentiation assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical inhibition plus rescue with heparin, multiple orthogonal methods\",\n      \"pmids\": [\"1379245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"FGF4 protein expressed in the enamel knot stimulates proliferation of both dental epithelial and mesenchymal cells in vitro, while the enamel knot cells themselves do not divide, supporting a paracrine growth-stimulating role during tooth cusp morphogenesis.\",\n      \"method\": \"In situ hybridization, in vitro FGF4 protein addition to isolated dental tissues, cell proliferation assessment\",\n      \"journal\": \"The International journal of developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro FGF4 protein addition with proliferation readout, single lab\",\n      \"pmids\": [\"7848830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"FGF4 promotes differentiation of parietal endoderm from isolated inner cell mass (ICM) cells and increases secretion of 92 kDa gelatinase and tissue plasminogen activator; FGFR-3 and FGFR-4 receptors are expressed on all blastocyst cells.\",\n      \"method\": \"Immunosurgery ICM isolation, recombinant FGF4 culture, morphological analysis, zymography, receptor expression by Northern blot\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein addition to isolated ICM with defined cellular readouts, single lab\",\n      \"pmids\": [\"7925026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"FGF4 angiogenic activity is demonstrated in vivo by chick chorioallantoic membrane assay and rat cornea assay using recombinant hst-1 protein produced in E. coli.\",\n      \"method\": \"Recombinant protein production in E. coli, CAM assay, rat cornea assay, nude mouse tumor vascularization\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two in vivo angiogenesis assays with recombinant protein, single lab\",\n      \"pmids\": [\"7520355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The FGF4 gene is positively regulated by an upstream NF-Y binding site (sequence CTGATTGGCA) in its promoter that cooperates with the downstream octamer enhancer in F9 embryonal carcinoma cells.\",\n      \"method\": \"CAT reporter assays, deletion/mutation analysis, EMSA, methylation interference, anti-NF-Y antibody supershift\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay with mutagenesis + EMSA + antibody validation, single lab\",\n      \"pmids\": [\"7929190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Adenovirus-mediated HST-1/FGF4 gene transfer in vivo causes a twofold increase in peripheral platelet count and increased megakaryocyte numbers in bone marrow and spleen, demonstrating an in vivo thrombopoietic role.\",\n      \"method\": \"Adenovirus-mediated gene transfer in nude mice, platelet counting, histology of bone marrow and spleen, recombinant protein injection\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — adenoviral gene delivery in vivo with defined hematological phenotype, single lab\",\n      \"pmids\": [\"7809043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"FGF-4 gene expression requires synergistic action of Sox2 and Oct-3 on adjacent binding sites in the downstream enhancer; Sox2 forms a ternary complex with Oct-3 (but not Oct-1) on FGF-4 enhancer DNA, and only the Sox2/Oct-3 complex drives transcriptional activation.\",\n      \"method\": \"cDNA cloning of Sox2 from F9 cells, CAT reporter assays, EMSA, ternary complex formation experiments\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ternary complex reconstitution on defined DNA element + reporter assays with multiple factor combinations, strong mechanistic evidence\",\n      \"pmids\": [\"7590241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Homozygous disruption of Fgf4 by gene targeting causes early postimplantation lethality with severely impaired inner cell mass proliferation; this ICM proliferation defect is rescued by exogenous FGF4 protein in vitro, demonstrating an essential mitogenic role for FGF4 in early embryogenesis.\",\n      \"method\": \"Gene targeting (knockout), embryo culture, exogenous FGF4 protein rescue experiment\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — loss-of-function genetic model + protein rescue, foundational paper\",\n      \"pmids\": [\"7809630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"HST-1/FGF4 antisense oligodeoxynucleotides block mouse limb bud outgrowth in an organ culture system, while sense and scrambled ODNs have no effect, establishing a required role for FGF4 in limb development.\",\n      \"method\": \"Antisense oligodeoxynucleotide treatment, limb bud organ culture, morphological assessment\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — antisense knockdown with defined limb phenotype and controls, single lab\",\n      \"pmids\": [\"7642715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Adenovirus-mediated FGF4 gene transfer effectively prevents chemotherapy- and irradiation-induced thrombocytopenia in mice by stimulating megakaryocyte production, with sustained serum FGF4 elevation for ≥30 days.\",\n      \"method\": \"Adenoviral gene transfer, thrombocytopenic mouse model (chemotherapy/irradiation), platelet counting, bone marrow histology\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gene delivery with defined hematological rescue phenotype, single lab\",\n      \"pmids\": [\"7635948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"FGF4 produced by the AER promotes trophoblast stem cell proliferation; culture of mouse blastocysts or early postimplantation trophoblasts with FGF4 allows isolation of permanent trophoblast stem cell lines that differentiate in vitro upon FGF4 withdrawal.\",\n      \"method\": \"Blastocyst culture with recombinant FGF4, trophoblast stem cell line derivation, in vitro differentiation, in vivo chimera analysis\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — FGF4 addition/withdrawal experiments with defined stem cell and differentiation readouts, replicated across multiple cell lines and in vivo chimeras, highly cited foundational paper\",\n      \"pmids\": [\"9851926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"FGF4 antagonizes BMP-induced apoptosis and BMP-induced chondrogenesis in chick limb buds; FGF4 prevents BMP-mediated mesenchyme apoptosis and nullifies BMP4-induced ectopic chondrogenesis when co-applied.\",\n      \"method\": \"Bead implantation into chick limb buds, apoptosis assessment, chondrocyte condensation analysis\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo bead implantation with defined cellular readouts, single lab\",\n      \"pmids\": [\"9507096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"FGF4 in the AER is maintained by a SHH/FGF4 feedback loop: SHH signaling in the posterior mesenchyme induces Gremlin (a BMP antagonist) which relays the signal to induce Fgf4 expression in the AER; grafting Gremlin-expressing cells into limb deformity mutant limb buds rescues Fgf4 expression.\",\n      \"method\": \"Mouse mutant analysis (Shh-null, limb deformity mutants), Gremlin cell grafting rescue experiment, in situ hybridization\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in multiple mutants + cell graft rescue, replicated across multiple mutant lines\",\n      \"pmids\": [\"10524628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"FGF4 provides a vertical signal (from notochord) that induces En1 expression in the midbrain neural plate; exogenous FGF4 mimics the notochord requirement for En1 induction in neural plate explants in vitro.\",\n      \"method\": \"Avian embryo tissue recombination, notochord ablation, FGF4 protein addition to neural plate explants in vitro\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — tissue recombination + protein addition with defined molecular readout, single lab\",\n      \"pmids\": [\"9927596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Conditional inactivation of Fgf4 in the mouse AER using Cre/loxP results in normal limb development with normal Shh, Bmp2, Fgf8, and Fgf10 expression, demonstrating that FGF4 alone is not essential for AER-mediated limb patterning and that the FGF4-SHH feedback loop is not required.\",\n      \"method\": \"Conditional knockout (Cre/loxP), limb morphology analysis, in situ hybridization for target genes\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — conditional genetic loss-of-function with reporter and molecular readouts, well-controlled study\",\n      \"pmids\": [\"10662638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Conditional inactivation of Fgf4 in the mouse AER does not impair Shh expression or limb formation, but Shh is required for maintenance of Fgf9 and Fgf17 (but not Fgf8) in the AER; combined activities of multiple AER-FGFs function in the positive feedback loop with Shh.\",\n      \"method\": \"Conditional knockout (Cre/loxP), double mutant analysis, in situ hybridization\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — conditional KO with epistasis analysis across multiple FGF genes, replicated the Moon 2000 result independently\",\n      \"pmids\": [\"10802662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Misexpression of Fgf-4 in the chick limb inhibits myogenesis by downregulating the FGF receptor Frek in muscle progenitors, leading to decreased myoblast proliferation and inhibition of terminal differentiation.\",\n      \"method\": \"Replication-competent retrovirus (RCAS) overexpression in chick limb, quail-chick transplantation cell tracking, in situ hybridization for muscle markers\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — retroviral overexpression with cell tracking and molecular readout, single lab\",\n      \"pmids\": [\"11319857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"FGF4 is a direct transcriptional target of LEF1/Wnt signaling; LEF1 binds the Fgf4 promoter, Fgf4 is absent in Lef1-null tooth rudiments, and FGF4-soaked beads fully rescue the developmental arrest of Lef1-/- tooth germs. FGF4 then induces Fgf3 in dental mesenchyme and both epithelial and mesenchymal FGFs induce Shh.\",\n      \"method\": \"Lef1 knockout analysis, chromatin immunoprecipitation/reporter assay for LEF1 binding to Fgf4, bead rescue experiment in Lef1-/- tooth organ culture\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct transcriptional target identification + genetic rescue by protein application, multiple orthogonal methods\",\n      \"pmids\": [\"12502739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Fgf4 expressed in limb muscle is required for maintenance of tendon markers scleraxis and tenascin; exogenous FGF4 restores scleraxis and tenascin expression in muscleless and aneural limbs, but does not restore Fgf8 expression in tendons.\",\n      \"method\": \"Muscleless and aneural chick limb models, FGF4 bead implantation, in situ hybridization for tendon markers\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-FGF4-source model with bead rescue and molecular readouts, single lab\",\n      \"pmids\": [\"12086472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"FGF4 acts paraculturally to maintain trophectoderm and primitive endoderm identity at E4.5; loss of zygotic FGF4 leads to failure of differentiation and function of extraembryonic cell types rather than a strictly mitogenic defect.\",\n      \"method\": \"Fgf4 null embryo analysis, in vitro culture experiments with FGF4 protein\",\n      \"journal\": \"Genesis (New York, N.Y. : 2000)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with defined lineage phenotype, single lab\",\n      \"pmids\": [\"12748966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"FGF-4 induces proliferation of cardiac cushion mesenchymal cells; FGF-4 protein localizes in cushion mesenchyme and activates FGFR2, and retroviral overexpression of FGF-4 in vivo expands cushion mesenchyme toward the lumen, promoting early valve leaflet formation.\",\n      \"method\": \"Immunolocalization, in situ hybridization for FGFRs, BrdU incorporation assay, retroviral FGF-4 overexpression in chick embryo, FGF-4 microinjection with BrdU\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo proliferation assays with retroviral overexpression and protein injection, single lab\",\n      \"pmids\": [\"12798286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Combined loss of Fgf4 and Fgf8 in the forelimb AER causes failure of limb bud mesenchyme survival and loss of Shh and Fgf10 expression, demonstrating that FGF4 functionally compensates for FGF8 in supporting limb mesenchyme viability.\",\n      \"method\": \"Double conditional knockout (Cre/loxP for Fgf4 and Fgf8), apoptosis analysis, in situ hybridization for Shh and Fgf10\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — double conditional KO with defined apoptotic phenotype and molecular marker analysis\",\n      \"pmids\": [\"15328019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HST-1/FGF-4 protects male germ cells from heat-stress-induced apoptosis by activating the MAPK survival cascade in germ cells and by stimulating lactate production from Sertoli cells, which is an indispensable nutrient for germ cell survival.\",\n      \"method\": \"Adenoviral FGF4 gene delivery to mouse testes, hyperthermia model, TUNEL apoptosis assay, MAPK activation by western blot, lactate production measurement\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — adenoviral gain-of-function with TUNEL, signaling, and metabolic readouts, single lab\",\n      \"pmids\": [\"14980503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"FGF4 can functionally replace FGF8 in limb skeletal development: when Fgf4 is expressed in place of Fgf8 via conditional allele switching, all Fgf8 inactivation-induced skeletal defects are rescued; excess FGF4 signaling causes polydactyly and syndactyly.\",\n      \"method\": \"Conditional Fgf4 gain-of-function allele activation simultaneous with Fgf8 inactivation via Cre recombinase, skeletal preparation analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — conditional allele-swap genetic rescue with defined skeletal phenotype, elegant single-experiment proof of functional equivalence\",\n      \"pmids\": [\"16308330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The histone demethylase KDM7A (KIAA1718) directly activates FGF4 transcription by removing repressive H3K9me2 and H3K27me2 marks at the FGF4 locus; knockdown of KDM7A blocks neural differentiation and this is rescued by wild-type but not catalytically inactive KDM7A; this pro-neural effect is mediated through FGF4.\",\n      \"method\": \"KDM7A knockdown in mouse ESCs, rescue with wild-type vs. catalytic mutant KDM7A, ChIP for histone marks at Fgf4 locus, neural differentiation assays\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP for direct histone mark changes at Fgf4 locus + catalytic mutant rescue, multiple orthogonal methods\",\n      \"pmids\": [\"20084082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Loss of both Fgf4 and Fgf8 during late gastrulation results in failure to maintain paraxial mesoderm progenitors in the epiblast/tailbud, causing severe vertebral/rib defects, loss of Wnt3a and Brachyury expression, and cessation of somitogenesis after ~15–20 somites.\",\n      \"method\": \"Double conditional knockout (Cre/loxP) for Fgf4 and Fgf8, skeletal preparation, in situ hybridization for Wnt3a, Brachyury, and Notch pathway genes, BrdU/apoptosis analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — double conditional KO with defined axial elongation phenotype and molecular pathway dissection\",\n      \"pmids\": [\"22954964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ARTD1/PARP1 PARylates Sox2, promoting Sox2 binding to the FGF4 enhancer and activating FGF4 expression during early reprogramming; exogenous FGF4 restores reprogramming capacity of Artd1-/- fibroblasts to wild-type levels, placing FGF4 downstream of ARTD1-Sox2 in the reprogramming pathway.\",\n      \"method\": \"Artd1 knockout fibroblasts, ARTD1 inhibitor treatment, ChIP for Sox2 at Fgf4 enhancer, exogenous FGF4 rescue of reprogramming efficiency\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP + KO + chemical inhibition + genetic rescue, multiple orthogonal methods\",\n      \"pmids\": [\"23939864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"FGF4 is the major limiting FGF in the preimplantation embryo controlling the ratio of primitive endoderm (PE) to epiblast (EPI) in the ICM; titrated exogenous FGF4 progressively increases PE proportions in a dose-dependent manner regardless of embryo genotype.\",\n      \"method\": \"Fgf4 hypomorphic/null mutant embryo series, exogenous FGF4 dose-response treatment, lineage marker analysis (GATA6/Nanog immunofluorescence)\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genetic dosage series + dose-response protein addition with quantitative lineage readout\",\n      \"pmids\": [\"24063807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FGF4 signaling (via FGFR and ERK) is required for primitive endoderm specification in the ICM; Klf5 acts as an upstream repressor of Fgf4, as Klf5 knockout embryos show markedly upregulated Fgf4 and skewed PE specification, which is reversed by FGFR/ERK inhibitors.\",\n      \"method\": \"Klf5 knockout embryo analysis, FGFR/ERK inhibitor treatment, immunofluorescence for PE/EPI markers, Klf5 overexpression embryos\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — KO + pharmacological epistasis + OE with defined lineage phenotype, multiple approaches\",\n      \"pmids\": [\"28870993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"O-GlcNAcylation of PKCζ at its phosphorylation site inhibits PKCζ activation and consequently suppresses the FGF4-PKCζ-MEK-ERK1/2 signaling pathway in mouse embryonic stem cells, maintaining the undifferentiated state.\",\n      \"method\": \"O-GlcNAc inhibitor/enhancer treatment in ESCs, PKCζ mutagenesis, MEK/ERK phosphorylation western blot, FGF4 stimulation assays\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological manipulation of O-GlcNAc + PKCζ mutagenesis + signaling readout, single lab\",\n      \"pmids\": [\"29249667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Sox2 expression level (more than Oct4) drives synergistic binding to the Fgf4 Sox/Oct composite motif; quantitative fluorescence correlation spectroscopy shows that binding affinity of Oct4/Sox2 heterodimer to the Fgf4 regulatory element is primarily determined by the Sox2 concentration, explaining how Sox2 fluctuations control epiblast/PE lineage segregation via FGF4.\",\n      \"method\": \"Fluorescence correlation spectroscopy (FCS) binding affinity measurements for Oct4 and Sox2 on Fgf4 Sox/Oct motif\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — quantitative biophysical binding measurement, single lab\",\n      \"pmids\": [\"29487166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FGF4 acts as a short-range paracrine signal mediating cell-cell communication that generates and maintains robust proportions of epiblast-like and primitive endoderm-like cells in mouse ESC cultures; FGF4 signaling enables autonomous re-establishment of cell-type proportions after perturbation.\",\n      \"method\": \"ESC culture with FGF4 signaling manipulation, cell-type proportion quantification, mathematical modeling, perturbation-restoration experiments\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined signaling perturbation with quantitative population-level readout, single lab\",\n      \"pmids\": [\"34651174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FGF4 protects the liver from NAFLD by activating hepatic FGFR4, which triggers a Ca2+/CaMKKβ-dependent AMPK-Caspase 6 signaling axis, leading to enhanced fatty acid oxidation and reduced hepatocellular apoptosis; hepatic Fgf4 deletion aggravates steatosis.\",\n      \"method\": \"Hepatic Fgf4 knockout mouse, recombinant FGF4 pharmacological treatment, FGFR4 blocking, AMPK and Caspase 6 pathway analysis, dietary NAFLD/NASH models\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — liver-specific KO + pharmacological gain-of-function + receptor-specific blockade + downstream signaling characterization, multiple orthogonal methods\",\n      \"pmids\": [\"35152446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FGF4 inhibits hepatocyte ferroptosis in autoimmune hepatitis by upregulating CISD3 and activating Nrf2/HO-1 signaling; Fgf4 depletion increases lipid peroxidation and iron accumulation, while recombinant FGF4 rescues ferroptotic markers (xCT, GPX4) in an erastin-induced model.\",\n      \"method\": \"Hepatic Fgf4 knockout mouse, recombinant FGF4 treatment, CISD3 overexpression/knockdown, Erastin-induced ferroptosis model in AML12 cells, TUNEL/lipid peroxidation assays\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO + protein rescue + downstream target manipulation with defined ferroptosis readouts, single lab\",\n      \"pmids\": [\"36702076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Hepatic FGF4 is a direct transcriptional target of FXR that acts as a paracrine signal to downregulate bile acid synthesis genes Cyp7a1 and Cyp8b1 via an intracellular FGFR4-LRH-1 signaling node; this pathway functions upstream of the peripheral FXR-FGF15/19 pathway as a first-line checkpoint for intrahepatic bile acid homeostasis.\",\n      \"method\": \"Hepatic Fgf4 conditional knockout, FXR chromatin immunoprecipitation, FGFR4 signaling analysis, LRH-1 pathway analysis, cholestatic mouse models, recombinant FGF4 treatment\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct FXR-ChIP identification of Fgf4 as target + conditional KO + receptor/downstream pathway dissection + pharmacological rescue, multiple orthogonal methods\",\n      \"pmids\": [\"39393353\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FGF4 is a secreted heparan-sulfate-binding growth factor whose transcription in pluripotent/embryonic cells is driven by a Sox2/Oct-3 ternary complex on a downstream enhancer (regulated by KDM7A demethylation and ARTD1-mediated Sox2 PARylation); it signals through FGF receptors (primarily FGFR2 and FGFR4) and heparan sulfate proteoglycans to activate PKCζ-MEK-ERK1/2 and AMPK-Caspase 6 cascades, functioning as a critical paracrine/autocrine mitogen and differentiation signal in trophoblast stem cell maintenance, ICM primitive endoderm/epiblast proportioning, limb bud mesenchyme survival (where it is functionally redundant with FGF8), axial elongation, tooth and cardiac valve morphogenesis, bile acid homeostasis via hepatic FGFR4-LRH-1 signaling, and protection of liver and germ cells from stress-induced cell death.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FGF4 is a secreted, heparan-sulfate-dependent fibroblast growth factor that functions as a paracrine and autocrine mitogen and differentiation signal across multiple developmental and metabolic contexts. Its transcription in pluripotent cells is driven by a Sox2/Oct-3 ternary complex on a downstream enhancer, with additional regulation by LEF1/Wnt signaling in dental epithelium and FXR in hepatocytes; epigenetic activation requires KDM7A-mediated removal of H3K9me2/H3K27me2, and Sox2 binding is promoted by ARTD1-dependent PARylation [PMID:7590241, PMID:12502739, PMID:20084082, PMID:23939864, PMID:39393353]. FGF4 signals through FGFR2 and FGFR4 to activate PKCζ–MEK–ERK1/2 and AMPK–Caspase 6 cascades, and is the principal FGF controlling the ratio of primitive endoderm to epiblast in the inner cell mass, maintaining trophoblast stem cells, and — redundantly with FGF8 — sustaining limb bud mesenchyme survival and axial elongation [PMID:24063807, PMID:9851926, PMID:15328019, PMID:22954964, PMID:29249667, PMID:35152446]. In postnatal tissues, hepatic FGF4 acts through an FGFR4–LRH-1 signaling node to repress bile acid synthesis genes Cyp7a1 and Cyp8b1 as a first-line intrahepatic checkpoint, protects hepatocytes from NAFLD-associated lipotoxicity and ferroptosis, and shields male germ cells from heat-stress apoptosis via MAPK activation [PMID:39393353, PMID:35152446, PMID:36702076, PMID:14980503].\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"Identification of FGF4 (hst) as an oncogene encoding a 206-aa protein sufficient for NIH3T3 transformation established the gene as a growth-promoting factor.\",\n      \"evidence\": \"cDNA cloning and expression-vector transfection transformation assay in NIH3T3 cells\",\n      \"pmids\": [\"2953031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No receptor or signaling pathway identified\", \"Endogenous expression context unknown\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Demonstrating that FGF4 transforming activity requires secretion and extracellular receptor engagement resolved whether FGF4 acts intracellularly or as a classical secreted ligand; concurrent identification of Oct4 binding at the FGF4 enhancer linked its expression to pluripotency.\",\n      \"evidence\": \"Signal-peptide deletion, KDEL-retention mutants, neutralizing antibodies, and suramin reversal in NIH3T3 assays; CAT reporter and EMSA in EC/ES cells\",\n      \"pmids\": [\"1990270\", \"1655808\", \"1723621\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific FGF receptor identity not determined\", \"Sox2 co-requirement not yet recognized\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Establishing heparan sulfate proteoglycan dependence for FGF4 activity defined a co-receptor requirement essential for signaling competence.\",\n      \"evidence\": \"Chlorate inhibition of sulfation abolishes FGF4 activity on MM14 myoblasts; heparin rescue restores signaling\",\n      \"pmids\": [\"1379245\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific HSPG species not identified\", \"In vivo relevance of HSPG requirement untested\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Multiple studies revealed FGF4's diverse paracrine roles — stimulating dental cell proliferation, promoting ICM parietal endoderm differentiation, driving angiogenesis, and increasing megakaryocyte/platelet production — extending its biology beyond simple oncogenic transformation.\",\n      \"evidence\": \"Recombinant FGF4 addition to dental tissues, isolated ICM, CAM/cornea angiogenesis assays, and adenoviral gene transfer in mice\",\n      \"pmids\": [\"7848830\", \"7925026\", \"7520355\", \"7809043\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor specificity for each tissue context unknown\", \"Dose-response relationships not established\", \"In vivo genetic confirmation lacking for most contexts\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"The Sox2/Oct-3 ternary complex mechanism was defined, and Fgf4-knockout lethality proved FGF4 is an essential embryonic mitogen whose loss causes ICM proliferation failure rescuable by exogenous protein.\",\n      \"evidence\": \"Ternary complex reconstitution on Fgf4 enhancer DNA with EMSA/reporter assays; homozygous Fgf4 gene targeting with embryo culture and FGF4 protein rescue\",\n      \"pmids\": [\"7590241\", \"7809630\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling pathway from FGFR in ICM not characterized\", \"Relative contributions of mitogenic vs. differentiation functions not separated\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"FGF4 was shown to be necessary and sufficient for trophoblast stem cell self-renewal, and to antagonize BMP-induced apoptosis in limb mesenchyme, establishing it as a key survival and stemness factor.\",\n      \"evidence\": \"TS cell derivation/maintenance with FGF4 addition/withdrawal and in vivo chimera analysis; FGF4 bead implantation in chick limb buds blocking BMP4-induced apoptosis\",\n      \"pmids\": [\"9851926\", \"9507096\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of downstream FGF receptor in trophoblast stem cells not defined\", \"Mechanism of BMP antagonism (convergent signaling vs. transcriptional) not resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Conditional AER-specific Fgf4 knockout yielded normal limbs, overturning the assumed essential role of FGF4 alone in limb patterning and revealing functional redundancy among AER-FGFs.\",\n      \"evidence\": \"Cre/loxP conditional knockout in two independent studies with limb morphology and in situ hybridization analysis\",\n      \"pmids\": [\"10662638\", \"10802662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which AER-FGF combination is minimally sufficient not yet tested\", \"Quantitative contribution of FGF4 vs. FGF8 undetermined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"FGF4 was identified as a direct transcriptional target of LEF1/Wnt signaling that mediates epithelial-mesenchymal cross-talk in tooth morphogenesis, broadening the upstream regulatory landscape beyond Oct4/Sox2.\",\n      \"evidence\": \"ChIP/reporter for LEF1 on Fgf4 promoter; FGF4-bead rescue of Lef1-null tooth arrest\",\n      \"pmids\": [\"12502739\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Wnt-dependent Fgf4 regulation operates in non-dental tissues unknown\", \"Mechanism of FGF4-induced Shh in mesenchyme not characterized\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Double Fgf4/Fgf8 conditional knockout proved that FGF4 and FGF8 are functionally redundant in sustaining limb mesenchyme survival and Shh expression, resolving why single Fgf4 loss had no limb phenotype.\",\n      \"evidence\": \"Double conditional knockout with apoptosis analysis and in situ hybridization for Shh and Fgf10\",\n      \"pmids\": [\"15328019\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FGF4/FGF8 redundancy extends to signaling pathway level or is purely quantitative not resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Allele-swap experiments demonstrated full functional interchangeability of FGF4 and FGF8 in limb skeletal development, establishing molecular equivalence at the receptor-activation level.\",\n      \"evidence\": \"Conditional Fgf4 gain-of-function allele activated simultaneously with Fgf8 inactivation via Cre; skeletal preparation analysis\",\n      \"pmids\": [\"16308330\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FGF4 and FGF8 activate identical downstream intracellular cascades not tested biochemically\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"KDM7A was shown to directly activate FGF4 transcription by removing repressive H3K9me2/H3K27me2 marks, linking chromatin state to FGF4 expression and neural differentiation.\",\n      \"evidence\": \"KDM7A knockdown in mouse ESCs with ChIP at Fgf4 locus; rescue with wild-type but not catalytic-dead KDM7A\",\n      \"pmids\": [\"20084082\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether KDM7A acts at the Fgf4 enhancer or promoter specifically not mapped at nucleosome resolution\", \"Interaction with Sox2/Oct4 complex not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Double Fgf4/Fgf8 loss during late gastrulation revealed that these FGFs maintain paraxial mesoderm progenitors and are required for axial elongation beyond ~15–20 somites.\",\n      \"evidence\": \"Double conditional knockout with skeletal preparation and in situ hybridization for Wnt3a, Brachyury, and Notch pathway genes\",\n      \"pmids\": [\"22954964\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contribution of FGF4 vs. FGF8 to tailbud progenitor maintenance not separable\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two advances refined FGF4's role in preimplantation development: ARTD1-mediated PARylation of Sox2 was shown to promote Sox2 occupancy at the FGF4 enhancer during reprogramming, and FGF4 dosage was identified as the primary determinant of primitive endoderm-to-epiblast ratio in the ICM.\",\n      \"evidence\": \"Artd1 KO fibroblasts with ChIP and FGF4 rescue of reprogramming; Fgf4 hypomorphic/null allelic series with quantitative lineage marker analysis\",\n      \"pmids\": [\"23939864\", \"24063807\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PARylation of Sox2 is constitutive or signal-regulated not known\", \"Identity of the FGFR mediating PE specification not confirmed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Downstream signaling was mapped: FGF4 activates a PKCζ–MEK–ERK1/2 cascade in ESCs (modulated by O-GlcNAcylation of PKCζ), and Klf5 was identified as an upstream transcriptional repressor of Fgf4 controlling PE specification.\",\n      \"evidence\": \"O-GlcNAc inhibitor/enhancer treatment with PKCζ mutagenesis and ERK phosphorylation readout; Klf5 KO embryos with FGFR/ERK inhibitor rescue\",\n      \"pmids\": [\"29249667\", \"28870993\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKCζ–ERK axis is the sole pathway downstream of FGFR in ESCs not tested\", \"Direct Klf5 binding to Fgf4 promoter not shown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A hepatoprotective function was uncovered: hepatic FGF4 signals through FGFR4 to activate a Ca²⁺/CaMKKβ–AMPK–Caspase 6 axis that promotes fatty acid oxidation and reduces apoptosis in NAFLD.\",\n      \"evidence\": \"Hepatic Fgf4 conditional knockout, recombinant FGF4 treatment, FGFR4 blockade, and AMPK/Caspase 6 pathway analysis in dietary NAFLD/NASH models\",\n      \"pmids\": [\"35152446\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FGF4 hepatoprotection is relevant in human NAFLD not tested\", \"Source cells producing hepatic FGF4 not fully characterized\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Hepatic FGF4 was identified as a direct FXR transcriptional target that represses bile acid synthesis via an FGFR4–LRH-1 signaling node, functioning as an intrahepatic first-line checkpoint upstream of the peripheral FGF15/19 pathway.\",\n      \"evidence\": \"FXR ChIP at Fgf4, hepatic Fgf4 conditional KO, FGFR4/LRH-1 pathway analysis, cholestatic mouse models, recombinant FGF4 rescue\",\n      \"pmids\": [\"39393353\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether human hepatocytes produce functionally equivalent FGF4 levels not demonstrated\", \"Relative quantitative contribution of FGF4 vs. FGF15/19 axis under physiological conditions unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: which FGFRs mediate FGF4 signaling in trophoblast stem cells and in PE specification; whether the PKCζ–ERK and AMPK–Caspase 6 cascades represent tissue-specific or general FGF4 signaling modes; and whether hepatic FGF4 functions are conserved in human liver physiology and disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Receptor identity for FGF4 in trophoblast stem cells and PE specification not confirmed\", \"Structural basis for FGF4/FGF8 interchangeability unknown\", \"Human translational relevance of hepatic FGF4 functions not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [1, 5, 6, 11, 14, 31, 36, 38]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [15, 31, 36]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [1, 2, 11, 14, 31]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 4, 33, 36, 38]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [11, 14, 16, 18, 25, 27, 29, 31]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [36, 38]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [10, 21, 28, 30, 38]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"FGFR2\",\n      \"FGFR4\",\n      \"SOX2\",\n      \"POU5F1\",\n      \"LEF1\",\n      \"KDM7A\",\n      \"ARTD1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}